Medicamen Biotech Performance
Day's Low
Day's High
₹451.3Day's Price Range₹45652 Week's Low
52 Week's High
₹355.4552-Week Price Range₹630
| Returns % | |
| 1 Month Return | -9.54 % |
| 3 Month Return | -17.29 % |
| 1 Year Return | -15.9 % |
| Market Stats | |
| Previous Close | ₹453.15 |
| Open | ₹453.00 |
| Volume | 8,757.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹576.16Cr |
Medicamen Biotech Key Statistics
| P/E Ratio | 99.59 |
| PEG Ratio | -17.32 |
| Market Cap | ₹576.16 Cr |
| P/B Ratio | 2.33 |
| EPS | 7.47 |
| Dividend Yield | 0.26 |
| Sector | Pharmaceuticals |
| ROE | 6.6 |
Medicamen Biotech Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹576.16 Cr | -3.58% | 0.57 | ₹9 Cr | ₹179 Cr | |
| NA | ₹5,044.92 Cr | 65.41% | 0.52 | -₹71 Cr | ₹1,704 Cr | |
| NA | ₹2,549.73 Cr | 83.05% | 0.56 | -₹15 Cr | ₹180 Cr | |
| NA | ₹712.10 Cr | 199.49% | 0.91 | ₹55 Cr | ₹575 Cr | |
| BUY | ₹7,153.68 Cr | 1547.17% | 0.55 | ₹95 Cr | ₹819 Cr |
About Medicamen Biotech
Share Price: ₹453.00 per share as on 30 Jan, 2025 09:23 AM
Market Capitalisation: ₹576.16Cr as of today
Revenue: ₹44.74Cr as on September 2024 (Q3 24)
Net Profit: ₹0.90Cr as on September 2024 (Q3 24)
Listing date: 27 Oct, 2021
Chairperson Name: Rahul Bishnoi
| Organisation | Medicamen Biotech |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Medicamen Biotech Ltd
Medicamen Biotech's Debt and Cash Position Raises Concerns - 04 Jul, 2024
Medicamen Biotech has ₹308.2m of debt, offset by ₹147.9m in cash, leading to net debt of about ₹160.3m. Its liabilities total ₹195.0m more than the combination of its cash and short-term receivables. While its low debt to EBITDA ratio suggests only modest use of debt, declining EBIT and burning a lot of cash over the last three years make its use of debt riskier.Medicamen Biotech Q4 Net Sales Up 22.38% YoY, Quarterly Profit Down by 43.54% - 18 Jun, 2024
Medicamen Bio's net sales for March 2024 increased by 22.38% YoY to Rs. 47.32 crore, while quarterly net profit decreased by 43.54% YoY to Rs. 2.13 crore. The EPS has also decreased from Rs. 3.03 in March 2023 to Rs. 1.61 in March 2024. Medicamen Bio shares have given -15.60% returns over the last 6 months and -27.71% over the last 12 months.Medicamen Biotech Q4 2023 Net Sales Up 21.16% YoY - 11 Jun, 2024
Medicamen Bio reported a 21.16% YoY increase in net sales for Q4 2023, with quarterly net profit at Rs. 3.10 crore, down 23.3% from the previous year. The company's EPS has decreased to Rs. 2.45 in March 2024 from Rs. 3.25 in March 2023. Medicamen Bio shares closed at 475.20 on June 10, 2024 (NSE) and have given -20.80% returns over the last 6 months and -28.28% over the last 12 months.
Insights on Medicamen Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 1.35 Cr → 1.46 Cr (in ₹), with an average increase of 7.5% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 55.77% to 56.04% in Dec 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 43.63 Cr → 45.03 Cr (in ₹), with an average increase of 3.1% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.2% return, outperforming this stock by 193.7%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.5% return, outperforming this stock by 68.9%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 42.99% of holdings in Dec 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 0.06% to 0.05% in Dec 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, MEDICAMEQ stock has moved down by -45.5%
Medicamen Biotech Financials
Medicamen Biotech Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 42.99% | 0.00 | |
| Foreign Institutions | 0.05% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 56.04% | 0.47 | |
| Others | 0.92% |
Medicamen Biotech Key Indicators
Medicamen Biotech Valuation
Medicamen Biotech in the last 5 years
Lowest (41.41x)
March 13, 2024
Industry (51.91x)
January 29, 2025
Today (99.59x)
January 29, 2025
Highest (132.87x)
December 6, 2024
Medicamen Biotech Earnings and Dividends
Medicamen Biotech Ltd Earnings Results
Medicamen Biotech Ltd’s net profit fell -3.31% since last year same period to ₹1.46Cr in the Q2 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated 8.15% jump in its net profits since last 3-months.
Read More about Earnings ResultsMedicamen Biotech Ltd Dividends May,2024
In the quarter ending March 2024, Medicamen Biotech Ltd has declared dividend of ₹1 - translating a dividend yield of 0.44%.
Read More about Dividends
Medicamen Biotech Technicals Summary
Bearish
Neutral
Bullish
Medicamen Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Medicamen Biotech Ltd
What is Medicamen Biotech Ltd price today?
Medicamen Biotech Ltd share price today stands at ₹453, Open: ₹453, Previous Close: ₹453.15, High: ₹456, Low: ₹451.3, 52 Week High: ₹630, 52 Week Low: ₹355.45.
How to Buy Medicamen Biotech Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Medicamen Biotech Ltd shares
Is Medicamen Biotech Ltd listed on NSE?
Medicamen Biotech Ltd is listed on NSE
Is Medicamen Biotech Ltd listed on BSE?
Medicamen Biotech Ltd is listed on BSE
What are today's High and Low prices of Medicamen Biotech Ltd?
- Today's highest price of Medicamen Biotech Ltd is ₹456.
- Today's lowest price of Medicamen Biotech Ltd is ₹451.3.
What are today's traded volumes of Medicamen Biotech Ltd?
Today's traded volume of Medicamen Biotech Ltd(MEDICAMEQ) is 8,757.00.
What is today's market capitalisation of Medicamen Biotech Ltd?
Today's market capitalisation of Medicamen Biotech Ltd(MEDICAMEQ) is ₹576.16Cr.
What is the 52 Week High and Low Range of Medicamen Biotech Ltd?
How much percentage Medicamen Biotech Ltd is down from its 52 Week High?
Medicamen Biotech Ltd (MEDICAMEQ) share price is ₹453. It is down -28.10% from its 52 Week High price of ₹630
How much percentage Medicamen Biotech Ltd is up from its 52 Week low?
Medicamen Biotech Ltd (MEDICAMEQ) share price is ₹453. It is up 27.44% from its 52 Week Low price of ₹355.45
What are the historical returns of Medicamen Biotech Ltd?
What is the PE ratio of Medicamen Biotech Ltd today?
PE Ratio of Medicamen Biotech Ltd is 99.59
PE ratio = Medicamen Biotech Ltd Market price per share / Medicamen Biotech Ltd Earnings per share